Olivia Newton-John Cancer Wellness and Research Centre

OrgUnit's Researchers
(Persons)

Results 1-5 of 45 (Search time: 0.003 seconds).

FullnameTranslated NameEmail
Berlangieri, AlexandraAlexandra.BERLANGIERI@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Berry, ColleenColleen.BERRY@austin.org.au
Brown, KerrynKez.Brown@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 861-880 of 927 (Search time: 0.017 seconds).

Publication YearTitleAuthor(s)
8611-Sep-2011Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.Sia, Joseph; Joon, Daryl Lim; Viotto, Angela ; Mantle, Carmel; Quong, George; Rolfo, Aldo; Wada, Morikatsu ; Anderson, Nigel; Rolfo, Maureen; Khoo, Vincent
86216-May-2022Toxicity associated with high-dose intravenous methotrexate for hematological malignancies.Wight, Joel C ; Ku, Matthew; Garwood, Melissa; Carradice, Duncan; Lasica, Masa; Keamy, Louise; Hawkes, Eliza A ; Grigg, Andrew P 
863Apr-2020Tracking Drug-Induced Epithelial-Mesenchymal Transition in Breast Cancer by a Microfluidic Surface-Enhanced Raman Spectroscopy Immunoassay.Zhang, Zhen; Wang, Jing; Shanmugasundaram, Karthik Balaji; Yeo, Belinda ; Möller, Andreas; Wuethrich, Alain; Lin, Lynlee L; Trau, Matt
8641-Jan-2021Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.Murphy, Alexandra C ; Koshy, Anoop N ; Cameron, William; Horrigan, Mark ; Kearney, Leighton; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B 
8656-Feb-2007Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis.Damianovich, D; Adena, M; Tebbutt, Niall C 
866Aug-2017Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian contextItchins, M; Chia, Puey Ling ; Hayes, SA; Howell, VM; Gill, AJ; Cooper, WA; John, Thomas ; Mitchell, Paul L R ; Millward, M; Clarke, SJ; Solomon, B; Pavlakis, N
8671-Sep-2005Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.Perera, Rushika M; Narita, Yoshitaka; Furnari, Frank B; Gan, Hui K ; Murone, Carmel ; Ahlkvist, Marika; Luwor, Rodney B; Burgess, Antony W; Stockert, Elisabeth; Jungbluth, Achim A; Old, Lloyd J; Cavenee, Webster K; Scott, Andrew M ; Johns, Terrance G
868Feb-2021Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive disease.Schmidt, Andrew ; Anton, Angelyn; Shapiro, Julia; Wong, Shirley; Azad, Arun; Kwan, Edmond; Spain, Lavinia; Muthusamy, Arun; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Joshua, Anthony M; Pook, David; Gibbs, Peter; Tran, Ben; Weickhardt, Andrew J 
869Apr-2020Treatment practice and outcomes in FLT3-mutant acute myeloid leukemia in the pre-midostaurin era: a real-world experience from Australian tertiary hospitals.Chua, Chong C; Grigg, Andrew P ; Singh, Jasmine; Droogleever, Mark P; Zhang, Lan; Lim, Andrew; Fong, Chun Y; Ting, Stephen B; Schwarer, Anthony; Tiong, Ing S ; Wei, Andrew H
870Nov-2019Treatment selection for first-line metastatic renal cell carcinoma in Australia: Impact of new therapy options.Schmidt, Andrew ; Azad, Arun; Goh, Jeffrey; Harris, Carole; Joshua, Anthony M; Weickhardt, Andrew; Krieger, Laurence
871Jul-2021Trend in stereotactic radiation therapy use for management of bone and brain metastases in patients with renal cell carcinoma in Australia.Ong, Wee Loon ; Siva, Shankar; Milne, Roger L; Foroudi, Farshad ; Millar, Jeremy L
872Apr-2021Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016.Ong, Wee Loon ; Evans, Sue M; Evans, Melanie; Tacey, Mark A ; Dodds, Lachlan; Kearns, Paul; Milne, Roger L; Foroudi, Farshad ; Millar, Jeremy
87328-Dec-2023Tribulations of trials in aggressive lymphoma.Barraclough, Allison ; Hawkes, Eliza A 
87423-Oct-2018TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II.Siva, Shankar; Chesson, Brent; Bressel, Mathias; Pryor, David; Higgs, Braden; Reynolds, Hayley M; Hardcastle, Nicholas; Montgomery, Rebecca; Vanneste, Ben; Khoo, Vincent; Ruben, Jeremy; Lau, Eddie ; Hofman, Michael S; De Abreu Lourenco, Richard; Sridharan, Swetha; Brook, Nicholas R; Martin, Jarad; Lawrentschuk, Nathan; Kron, Tomas; Foroudi, Farshad 
87526-Apr-2023A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.Walker, Romy; Mahmood, Khalid; Joo, Jihoon E; Clendenning, Mark; Georgeson, Peter; Como, Julia; Joseland, Sharelle; Preston, Susan G; Antill, Yoland; Austin, Rachel; Boussioutas, Alex; Bowman, Michelle; Burke, Jo; Campbell, Ainsley ; Daneshvar, Simin; Edwards, Emma; Gleeson, Margaret; Goodwin, Annabel; Harris, Marion T; Henderson, Alex; Higgins, Megan; Hopper, John L; Hutchinson, Ryan A; Ip, Emilia; Isbister, Joanne; Kasem, Kais; Marfan, Helen; Milnes, Di; Ng, Annabelle; Nichols, Cassandra; O'Connell, Shona; Pachter, Nicholas; Pope, Bernard J; Poplawski, Nicola; Ragunathan, Abiramy; Smyth, Courtney; Spigelman, Allan; Storey, Kirsty; Susman, Rachel; Taylor, Jessica A; Warwick, Linda; Wilding, Mathilda; Williams, Rachel; Win, Aung K; Walsh, Michael D; Macrae, Finlay A; Jenkins, Mark A; Rosty, Christophe; Winship, Ingrid M; Buchanan, Daniel D
87610-Jun-2021Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution.Lima, Luize G; Ham, Sunyoung; Shin, Hyunku; Chai, Edna P Z; Lek, Erica S H; Lobb, Richard J; Müller, Alexandra F; Mathivanan, Suresh; Yeo, Belinda ; Choi, Yeonho; Parker, Belinda S; Möller, Andreas
8773-Aug-2021Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin.Gan, Hui K ; Parakh, Sagun ; Lassman, Andrew B; Seow, Aidan; Lau, Eddie ; Lee, Sze Ting ; Ameratunga, Malaka; Perchyonok, Yuliya ; Cao, Diana; Burvenich, Ingrid J G; O'Keefe, Graeme J; Rigopoulos, Angela; Gomez, Erica; Maag, David; Scott, Andrew M 
878Jan-2017Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximabKu, Matthew; Chong, Geoff; Hawkes, Eliza A 
879Apr-2018Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.Ong, Wee Loon ; Evans, Sue M; Millar, Jeremy L
880Jun-2023Understanding the activity of antibody-drug conjugates in primary and secondary brain tumours.Mair, Maximilian J; Bartsch, Rupert; Le Rhun, Emilie; Berghoff, Anna S; Brastianos, Priscilla K; Cortes, Javier; Gan, Hui K ; Lin, Nancy U; Lassman, Andrew B; Wen, Patrick Y; Weller, Michael; van den Bent, Martin; Preusser, Matthias